A private equity company based in the Central United States has invested over $700 million throughout its lifetime, and is currently making investments out of its 12th fund, which raised $100 million. The firm is looking to make a growth equity allocation of around $3-$5 million initially, and up to $10 million over the lifetime of the investment. The firm will consider companies in any location, and is looking to make 4-5 investments over the next 12 months.
The PE invests in approved medical devices, healthcare IT, biotech R&D services and diagnostics. They have experience in delivery devices, implantable devices, and reusable instruments, so companies within these subsectors would be ideal. However, other medical devices may also be considered. The firm also has interest in the biotech R&D services sector, and in subsectors of CRO’s & diagnostic instrumentation.
The firm is looking to invest in a company with approximately $5 million in yearly revenue with a strong management team. They will consider small public or private companies for investment, and seek to acquire an active position on the company’s board.
Next Phase Newsletter 
Leave a comment